US Map / Illinois
State IL

Clinical Trials in Illinois

Illinois is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Illinois and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 417 actively recruiting studies with Illinois sites out of 417 registered in total. The busiest research areas in Illinois are Breast Cancer, Endometrial Cancer, Hypertension. Leading sponsors running trials in the state include University of Chicago, Northwestern University, University of Illinois at Chicago. By stage, Illinois trials break down as Phase 1 (66), Phase 2 (118), Phase 3 (105), Phase 4 (13).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
417
Recruiting Now
417
← Back to US Map
Top Conditions in Illinois
Breast Cancer (7)Endometrial Cancer (7)Hypertension (6)Advanced Solid Tumors (5)Obesity (5)Prostate Cancer (4)Solid Tumor (4)Knee Osteoarthritis (4)Kidney Transplant (4)Non-Small Cell Lung Cancer (4)Colorectal Cancer (4)Acute Myeloid Leukemia (4)

Frequently Asked Questions — Clinical Trials in Illinois

How many clinical trials are currently recruiting in Illinois?
ClinicalMetric currently tracks 417 actively recruiting clinical trials with at least one location in Illinois. The total number of registered studies—including active but not currently enrolling trials—is 417. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Illinois?
Illinois hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Endometrial Cancer, Hypertension, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Illinois serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Illinois?
To join a clinical trial in Illinois, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Illinois maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Illinois

NCT07806617 Phase 2
Recruiting
Intralesional Gardasil-9 for the Treatment of Recalcitrant Warts
Condition
Warts
Enrollment
55 pts
Location
United States
Sponsor
Rush University Medical Center
View Trial →
NCT02693535 Phase 2
Recruiting
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That...
Condition
Lymphoma, Non-Hodgkin
Enrollment
4,200 pts
Location
United States, Puerto Rico
Sponsor
American Society of Clinical O
View Trial →
NCT07361510 Phase 3
Recruiting
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participan...
Condition
Non-Small Cell Lung Cancer (NSCLC)
Enrollment
750 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
View Trial →
NCT06773910 Phase 2
Recruiting
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lu...
Condition
Limited Stage Small Cell Lung Cancer
Enrollment
250 pts
Location
United States
Sponsor
SCRI Development Innovations,
View Trial →
NCT04943848 Phase 1
Recruiting
rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG ...
Condition
Diffuse Intrinsic Pontine Glioma
Enrollment
36 pts
Location
United States
Sponsor
Ann & Robert H Lurie Children'
View Trial →
NCT06617325 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Part...
Condition
Systemic Lupus Erythematosus
Enrollment
450 pts
Location
United States, Argentina, Belgium
Sponsor
UCB Biopharma SRL
View Trial →
NCT06471374 N/A
Recruiting
Pathophysiology of Circadian Rhythm Delayed Sleep Wake Phase Disorder
Condition
Delayed Sleep Phase Syndrome
Enrollment
66 pts
Location
United States
Sponsor
University of Colorado, Boulde
View Trial →
NCT07052903 Phase 3
Recruiting
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloid...
Condition
Transthyretin Amyloidosis With Cardiomyopathy
Enrollment
1,750 pts
Location
United States, Argentina, Australia
Sponsor
Alnylam Pharmaceuticals
View Trial →
NCT06206486 N/A
Recruiting
The Gut Microbiome and Serum Metabolites as a Biological Mechanism Underlying Pa...
Condition
Kidney Transplant Symptoms
Enrollment
133 pts
Location
United States
Sponsor
University of Illinois at Chic
View Trial →
NCT06782295 Phase 4
Recruiting
The Use of CCK vs PS in Revision TKAs
Condition
Aseptic Loosening of Prosthetic Joint
Enrollment
170 pts
Location
United States
Sponsor
Rush University Medical Center
View Trial →
NCT06527157 N/A
Recruiting
Investigations of Reproductive Cancers in Women
Condition
Uterine Cancer
Enrollment
4,500 pts
Location
United States
Sponsor
PinkDx, Inc.
View Trial →
NCT06875973 Phase 3
Recruiting
Pelacarsen Roll-over Extension Program
Condition
Atherosclerotic Cardiovascular Disease
Enrollment
599 pts
Location
United States, Puerto Rico
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT06241456 Phase 1
Recruiting
FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibod...
Condition
Advanced Solid Tumor
Enrollment
351 pts
Location
United States
Sponsor
Fate Therapeutics
View Trial →
NCT07387445 N/A
Recruiting
Feasibility and Acceptibility of a Multi-site Trial of Time Restircted Eating Du...
Condition
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Enrollment
40 pts
Location
United States
Sponsor
University of Illinois at Chic
View Trial →
NCT06072781 Phase 3
Recruiting
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade ...
Condition
Low Grade Serous Ovarian Cancer
Enrollment
270 pts
Location
United States, Australia, Belgium
Sponsor
Verastem, Inc.
View Trial →
NCT05985772 N/A
Recruiting
Operative vs Non-operative Management of Posterior-medial Meniscal Root Tears: A...
Condition
Meniscus Tear, Tibial
Enrollment
140 pts
Location
United States
Sponsor
Rush University Medical Center
View Trial →
NCT07475702 N/A
Recruiting
Moon and Sun Brothers: A Community Prevention Intervention (Hermanos de Luna y S...
Condition
Help-Seeking Behavior
Enrollment
360 pts
Location
United States
Sponsor
San Francisco State University
View Trial →
NCT06885281 Phase 1, Phase 2
Recruiting
A Study of ZL-1310 in Participants With Selected Solid Tumors
Condition
Solid Tumors
Enrollment
166 pts
Location
United States, China
Sponsor
Zai Lab (Shanghai) Co., Ltd.
View Trial →
NCT06171269 N/A
Recruiting
Using MRI to Identify Areas to Receive Lower Doses of Radiation Treatment in Men...
Condition
Prostate Cancer
Enrollment
60 pts
Location
United States
Sponsor
University of Chicago
View Trial →
NCT07592273 Phase 2, Phase 3
Recruiting
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Particip...
Condition
Diabetic Retinopathy
Enrollment
576 pts
Location
United States, Puerto Rico
Sponsor
AbbVie
View Trial →
NCT06127407 Phase 3
Recruiting
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chon...
Condition
Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen
Enrollment
136 pts
Location
United States, Australia, Belgium
Sponsor
Servier Bio-Innovation LLC
View Trial →
NCT06603844 Phase 1, Phase 2
Recruiting
First-in-human Study of CRB-601-01 to Treat Patients With Advanced Solid Tumor.
Condition
Solid Tumor
Enrollment
156 pts
Location
United States, United Kingdom
Sponsor
Corbus Pharmaceuticals Inc.
View Trial →
NCT07200830 Phase 3
Recruiting
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA ...
Condition
Metastatic Castration-Resistant Prostate Carcinoma
Enrollment
1,524 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
View Trial →
NCT03723928 N/A
Recruiting
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Re...
Condition
Anatomic Stage IV Breast Cancer AJCC v8
Enrollment
739 pts
Location
United States, Guam, Puerto Rico
Sponsor
SWOG Cancer Research Network
View Trial →
NCT04317534 Phase 2
Recruiting
Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I N...
Condition
NSCLC, Stage I
Enrollment
244 pts
Location
United States
Sponsor
Greg Durm, MD
View Trial →
Page 1 of 17 — 417 trials total
Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology